Sunovion Pharmaceuticals and Novartis have entered a commercialization agreement for three drugs approved by the U.S. Food and…
Articles by Patrícia Silva, PhD
The National Heart, Lung and Blood Institute (NHLBI) has named the recipient of its inaugural Outstanding Investigator Award: Yvonne Janssen-Heininger, PhD, professor of…
The chief executive of education for health and chair of the UK Inhaler Group, Monica Fletcher, will join a…
Women who have never smoked are still vulnerable to develop chronic obstructive pulmonary disease (COPD). African-American women are especially susceptible…
InMed Pharmaceuticals announced that its research and development program using cannabinoids for the treatment of chronic obstructive pulmonary disease (COPD)…
The University of Newcastle (UON) in Australia was awarded a total of $10.8 million from the National Health and Medical Research…
Newly updated chronic obstructive pulmonary disease (COPD) management recommendations from the Global Initiative for Chronic Obstructive Lung Disease (GOLD)…
GlaxoSmithKline (GSK), together with Innoviva, recently announced GSK submitted a New Drug Application (NDA) with the U.S. FDA for the…
People with chronic obstructive pulmonary disease (COPD) often find it difficult to breathe, sometimes feeling like they breathing through a straw.
Confirmation of a diagnosis of chronic obstructive pulmonary disease (COPD) using pulmonary function testing is associated with not only a…